CosmosID provides award-winning, end-to-end microbiome solutions. They offer NGS, Metabolomics, Bioinformatics, as well as the world's most advanced microbiome analysis software, CosmosID-HUB: Microbiome.
The HUB relies on validated databases and algorithms specifically designed for maximum sensitivity, precision and lowest false positive rates. Unlike other solutions, CosmosID delivers strain-level results – we understand that the biologically informative and actionable unit in microbiology is not a genus or species, but ultimately a strain and its unique genetic and metabolic properties.
CosmosID was founded in 2008 by Dr. Rita Colwell, former director of the National Science Foundation and currently Distinguished University Professor at the University of Maryland and Johns Hopkins University Bloomberg School of Public Health. To learn more please visit www.cosmosid.com.
Industry
Biotechnology, Pharmaceutical preparations NES, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Diagnostic aids and tests NES, Scientific Research and Development Services, Services
HQ Location
20030 Century Blvd, Suite 300
Germantown, MD 20874, US
Keywords
MetagenomicsGenomicsBioinformaticsPathogen DetectioMicrobiomeEpidemiologyNext Gen SequencingMetabolomicssequencing servicescustom software development